Skip to content
OpenCapital
Get started

Ginkgo Bioworks DNA Q3 2025 earnings

Reported November 6, 2025 · After market close

Revenue$38.8MBeat by $1.3M
EPS-$1.45Miss by $0.21
Revenue estimate$37.6M
EPS estimate-$1.24

Next report

Aug 6, 2026 (In 1 week)
Revenue estimate$24.1M
EPS estimate-$0.90

Financials

Q3 2025

Income statement

See full
Revenue$38.8M-56.4%
Operating income-$90.0M-63.1%
Net income-$80.8M-43.2%
EPS (diluted)-$1.45-34.3%

Balance sheet

See full
Cash & equivalents$157.0M-76.3%
Total debt$422.9M-5.1%
Total equity$559.8M-29.8%
Total assets$1.2B-19.7%

Cash flow

See full
Operating cash flow-$31.6M+69.5%
CapEx--100%
Free cash flow-$31.6M+73.3%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$863.13M+90.6%
Enterprise value$1.13B+376%
P/S5.1×+3.0×

Profitability

See full
Operating margin-199.5%-47.7pp
Net margin-199.1%-49.8pp
FCF margin-109.8%-30.4pp

Returns & leverage

See full
Return on equity-50%-8.8pp
Debt / equity0.8×+0.2×
Current ratio4.4×-1.4×

Versus estimates

Revenue

Q1 2026$19.5MMiss by $23.5MQ4 2025$33.0MMiss by $4.1M
Q3 2025$38.8MBeat by $1.3M
Q2 2025$49.6MBeat by $10.7MQ1 2025$48.3MBeat by $6.7MQ4 2024$43.8MBeat by $5.2M

Diluted EPS

Q1 2026-$1.28Miss by $0.07Q4 2025-$1.42Beat by $0.38
Q3 2025-$1.45Miss by $0.21
Q2 2025-$1.10Beat by $0.34Q1 2025-$1.58Miss by $0.35Q4 2024-$1.82Miss by $0.37

Ask the moment Ginkgo Bioworks reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Ginkgo Bioworks report Q3 2025 earnings?
Ginkgo Bioworks (DNA) reported Q3 2025 earnings on November 6, 2025 after market close.
What were Ginkgo Bioworks's Q3 2025 revenue and EPS?
Ginkgo Bioworks reported revenue of $38.8M and eps of $-1.45 for Q3 2025.
Did Ginkgo Bioworks beat estimates in Q3 2025?
Revenue beat the consensus estimate of $37.6M by $1.3M. EPS missed the consensus estimate of $-1.24 by $0.21.
How did Ginkgo Bioworks's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 56.4% from $89.0M a year earlier and eps declined 34.3% from $-1.08.
Where can I find Ginkgo Bioworks's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001830214-25-000013) and the 10-Q periodic report (0001628280-25-050193) directly on SEC EDGAR. The filing index links above go to sec.gov.